The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial. uri icon

authors

  • Matthew S. Duprey, PharmD, PhD
  • Al-Qadheeb, Nada
  • Roberts, Russel
  • Skrobik, Yoanna
  • Schumaker, Greg
  • Devlin, John W

publication date

  • January 1, 2016